Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

2.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
4.

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.

Murphy BR, Hall SL, Kulkarni AB, Crowe JE Jr, Collins PL, Connors M, Karron RA, Chanock RM.

Virus Res. 1994 Apr;32(1):13-36. Review.

PMID:
8030364
5.

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

Crowe JE Jr.

Clin Infect Dis. 2001 Nov 15;33(10):1720-7. Epub 2001 Oct 5. Review.

PMID:
11595986
6.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
7.

Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

González PA, Bueno SM, Riedel CA, Kalergis AM.

Curr Med Chem. 2009;16(34):4609-25. Review.

PMID:
19903147
8.

Challenges in developing a pediatric RSV vaccine.

Schickli JH, Dubovsky F, Tang RS.

Hum Vaccin. 2009 Sep;5(9):582-91. Epub 2009 Sep 28. Review.

PMID:
19556888
9.

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.

Graham BS.

Immunol Rev. 2011 Jan;239(1):149-66. doi: 10.1111/j.1600-065X.2010.00972.x. Review.

11.

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Cranage M, Taylor G.

Expert Opin Biol Ther. 2005 Jul;5(7):939-52. Review.

PMID:
16018739
12.

Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development.

Brandenburg AH, Neijens HJ, Osterhaus AD.

Vaccine. 2001 Apr 6;19(20-22):2769-82. Review.

PMID:
11282187
13.

Prevention strategies for respiratory syncytial virus: passive and active immunization.

Englund JA.

J Pediatr. 1999 Aug;135(2 Pt 2):38-44. Review.

PMID:
10431138
14.

Mucosal vaccines against respiratory syncytial virus.

Yang K, Varga SM.

Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Review.

15.

New strategies for control of respiratory syncytial virus infection.

Nokes JD, Cane PA.

Curr Opin Infect Dis. 2008 Dec;21(6):639-43. doi: 10.1097/QCO.0b013e3283184245. Review.

PMID:
18978532
16.

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children.

Nair H, Verma VR, Theodoratou E, Zgaga L, Huda T, Simões EA, Wright PF, Rudan I, Campbell H.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S30. doi: 10.1186/1471-2458-11-S3-S30. Review.

17.

Active and passive immunisation against respiratory syncytial virus.

Zambon M.

Rev Med Virol. 1999 Oct-Dec;9(4):227-36. Review.

PMID:
10578118
18.
19.

Current progress on development of respiratory syncytial virus vaccine.

Chang J.

BMB Rep. 2011 Apr;44(4):232-7. doi: DOI 10.5483/BMBRep.2011.44.4.232. Review.

20.

Antigenic diversity of respiratory syncytial viruses and its implication for immunoprophylaxis in ruminants.

Duncan RB Jr, Potgieter LN.

Vet Microbiol. 1993 Nov;37(3-4):319-41. Review.

PMID:
8116189

Supplemental Content

Support Center